A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database
Condition(s):Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion; Infantile FibrosarcomaLast Updated:January 12, 2023Completed